ISSN 1662-4009 (online)

ey0019.4-4 | Important for clinical practice | ESPEYB19

4.4. Effects of growth hormone treatment on sleep-related parameters in adults with Prader-Willi syndrome

HH Shukur , L Hussain-Alkhateeb , Farholt S , O Norregaard , AP Jorgensen , C Hoybye

The Journal of Clinical Endocrinology & Metabolism, 2021, Vol. 106, No. 9, e3634–e3643PMID: 33950234Brief Summary: This trial explored the effects of rhGH treatment in patients with Prader-Willi syndrome (PWS) on respiratory and sleep parameters. The trial was randomized and placebo-controlled for 1 year, followed by a 2-year, open-phase GH treatment period. Polysomnography performed every 6 months revealed no adverse effects of rhGH tr...

ey0019.4-6 | Important for clinical practice | ESPEYB19

4.6. Serum testosterone and oestradiol predict the growth response during puberty promoting treatment

H Huttunen , T Varimo , H Huopio , R Voutilainen , S Tenhola , PJ Miettinen , T Raivio , M Hero

Clinical Endocrinology. 2022; 96:220–226. PMID: 34596269Brief Summary: This randomized controlled trial evaluated the effects of testosterone and aromatase inhibitor treatment on anthropometric measures, and their correlation with estradiol and testosterone serum levels in boys with constitutional delay of growth and puberty (CDGP), to elucidate the respective roles of the two sex steroid hormones on growth during puberty. The results sugge...

ey0019.5-1 | Novel treatments for rare skeletal disorders | ESPEYB19

5.1. Targeting TGF-β for treatment of osteogenesis imperfecta

IW Song , SC Nagamani , D Nguyen , I Grafe , VR Sutton , FH Gannon , E Munivez , MM Jiang , A Tran , M Wallace , P Esposito , S Musaad , E Strudthoff , S McGuire , M Thornton , V Shenava , S Rosenfeld , S Huang , R Shypailo , E Orwoll , B Lee

J Clin Invest. 2022 Apr 1;132(7):e152571. doi: 10.1172/JCI152571.Abstract: https://pubmed-ncbi-nlm-nih-gov.proxy.kib.ki.se/35113812/In brief: Currently, there is no disease-specific therapy for osteogenesis imperfecta (OI) where most children, of all forms of OI, with significant fracture history, are managed by bisphosphonates...

ey0019.5-6 | Advances in clinical practice | ESPEYB19

5.6. Vitamin D level and fractures in children and adolescents: a systematic review and meta-analysis

C Zheng , H Li , S Rong , L Liu , K Zhen , K Li

Bone Miner Metab. 2021 Sep;39(5):851-857Abstract: https://pubmed-ncbi-nlm-nih-gov.proxy.kib.ki.se/34115219/In brief: Vitamin D plays a pivotal role in calcium homeostasis and bone health; a question is therefore frequently raised regarding the risk of fractures in children with vitamin D deficiency. This is more pertinent in safeguarding cases where it is not uncommon to fin...

ey0019.7-3 | Clinical Guidance | ESPEYB19

7.3. FSH-stimulated inhibin b (FSH-iB): a novel marker for the accurate prediction of pubertal outcome in delayed puberty

S Chaudhary , R Walia , A Bhansali , D Dayal , N Sachdeva , T Singh , SK Bhadada

J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3495-e3505. doi: 10.1210/clinem/dgab357. PMID: 34010394https://academic.oup.com/jcem/article-abstract/106/9/e3495/6278376Brief Summary: This prospective interventional study evaluates the stimulation of inhibin B by exogenous FSH as a promising predictor of spontaneous ...

ey0019.11-1 | Genetic obesity: findings in clinical cohorts – how to interpret results? | ESPEYB19

11.1. Testing for rare genetic causes of obesity: findings and experiences from a pediatric weight management program

KJ Roberts , AJ Ariza , K Selvaraj , M Quadri , C Mangarelli , S Neault , EE Davis , HJ Binns

robertkj@uwm.edu International Journal of Obesity 2022 May 13:1–9. doi: 10.1038/s41366-022-01139-7. https://pubmed.ncbi.nlm.nih.gov/35562395/Brief Summary: This exploratory study presents the findings and experiences from n=117 children with obesity (BMI ≧97th percentile for age...

ey0019.11-8 | New predictors of obesity development | ESPEYB19

11.8. Why do humans undergo an adiposity rebound? Exploring links with the energetic costs of brain development in childhood using MRI-based 4D measures of total cerebral blood flow

JE Aronoff , A Ragin , C Wu , M Markl , S Schnel , A Shaibani , C Blair , CW Kuzawa

kuzawa@northwestern.edu Int J Obes (Lond). 2022 May;46(5):1044–1050. doi: 10.1038/s41366-022-01065-8. Epub 2022 Feb 8. https://pubmed.ncbi.nlm.nih.gov/35136192/Brief Summary: This cross-sectional study measured total cerebral blood flow (TCBF) by MRI in 82 healthy individuals (ages 0&#...

ey0019.13-9 | Diabetes | ESPEYB19

13.9. Global estimates of incidence of type 1 diabetes in children and adolescents: results from the International Diabetes Federation atlas, 10th edition

GD Ogle , S James , D Dabelea , C Pihoker , J Svennson , J Maniam , EL Klatman , CC Patterson

grahamo@diabetesnsw.com.au Diabetes Res Clin Pract 2022, 183:109083. doi: 10.1016/j.diabres.2021.109083Brief Summary: The incidence of Type 1 diabetes (T1D) in children and adolescents is increasing in many nations. The 10th edition of the International Diabetes Federation Atlas reports that an estimated 108,300 youth aged < 15 years a...

ey0019.14-12 | Risk and Outcome | ESPEYB19

14.12. Smoking during pregnancy is associated with child overweight independent of maternal pre-pregnancy BMI and genetic predisposition to adiposity

Schnurr Theresia M , Angquist Lars , Nohr Ellen Aagaard , Hansen Torben , Sorensen Thorkild I.A. , Morgen Camilla S

Scientific Reports (2022)12:3135 doi: 10.1038/s41598-022-07122-6Brief Summary: This case cohort study, based on the Danish National Birth Cohort (DNBC) with ~100 000 women and their children, investigated whether maternal smoking in pregnancy is associated with child BMI and risk for child overweight, independent of maternal pre-pregnancy BMI, genetic predisposition to adiposity and socio-...

ey0017.2-4 | Neonatal Hypoglycaemia | ESPEYB17

2.4. Targeting glucose control in preterm infants: Pilot studies of continuous glucose monitoring

L Thomson , D Elleri , S Bond , J Howlett , DB Dunger , K Beardsall

To read the full abstract: Arch Dis Child Fetal Neonatal Ed. 2019 Jul;104(4):F353–F359. PMID:30232094.In preterm and in the very low birthweight infants, hyperglycaemia is associated with increased risks of mortality, brain injury, retinopathy of prematurity and worse neurodevelopmental outcomes (1). Treatment of hyperglycaemia with continuous insulin infusion leads to increas...